Large-Vessel Involvement Is an Independent Risk Factor Predicting GCA Mortality
Trial Data Reveals the Limitations of Steroids in Giant Cell Arteritis Therapy
Updates on Giant Cell Arteritis
New Recommendations Guide Imaging in Large-Vessel Vasculitis
Higher Fracture Risk in Patients with Polymyalgia Rheumatica, Giant-Cell Arteritis
Tocilizumab Is Effective to Treat GCA
FDA Update: Romosozumab’s Uncertain Future; Plus Tocilizumab Approved for GCA
FDA Considers Tocilizumab for GCA & Piclidenoson Enters Phase 3 Trial for RA, Psoriasis
